MTDH and breast carcinoma: Previous studies from our group have also shown a significant correlation between MTDH expression with patients' age, ER status and p53 status that are also poor prognostic features, further supporting the notion that MTDH expression is correlated with poor prognosis and high morbidity in breast cancer patients [15].